WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$152M |
| 3 |
Brown & Brown
BRO
|
$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
$113M |
| 5 |
Akero Therapeutics
AKRO
|
$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
$144M |
| 2 |
MetLife
MET
|
$97.2M |
| 3 |
Travelers Companies
TRV
|
$91.9M |
| 4 |
Electronic Arts
EA
|
$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Welltower
WELL
$112B
| $10.3M | 0.05% |
67,056
+15,732
| +31% | +$2.42M |
|
427
Progress Software
PRGS
$1.88B
| $10.3M | 0.05% |
161,320
+35,270
| +28% | +$2.25M |
|
428
Viatris
VTRS
$12.2B
| $10.3M | 0.05% |
1,151,423
+6,682
| +0.6% | +$59.7K |
|
|
MBX
429
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $10.3M | 0.05% |
901,103
+23,642
| +3% | +$270K |
|
430
Genmab
GMAB
$16.9B
| $10.2M | 0.05% |
+493,506
| New | +$10.2M |
|
431
BioNTech
BNTX
$27B
| $10.2M | 0.05% |
95,498
-22,000
| -19% | -$2.34M |
|
432
Arcturus Therapeutics
ARCT
$485M
| $10.2M | 0.05% |
780,442
| – | – |
|
433
Penske Automotive Group
PAG
$12.4B
| $10.1M | 0.05% |
+58,861
| New | +$10.1M |
|
|
PVLA
434
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $10M | 0.05% |
445,615
+251,448
| +130% | +$5.67M |
|
435
Dynavax Technologies
DVAX
$1.18B
| $10M | 0.05% |
1,012,044
-166,719
| -14% | -$1.65M |
|
436
Chart Industries
GTLS
$8.96B
| $10M | 0.05% |
+60,720
| New | +$10M |
|
437
Ultragenyx Pharmaceutical
RARE
$3.07B
| $9.94M | 0.05% |
273,251
+4,789
| +2% | +$174K |
|
438
Duke Energy
DUK
$93.8B
| $9.92M | 0.05% |
84,074
+18,514
| +28% | +$2.18M |
|
|
STKL
439
SunOpta
STKL
$779M
| $9.91M | 0.05% |
1,709,033
+205,734
| +14% | +$1.19M |
|
|
SAIL
440
SailPoint, Inc. Common Stock
SAIL
$12.2B
| $9.79M | 0.05% |
428,371
| – | – |
|
441
KKR & Co
KKR
$121B
| $9.74M | 0.05% |
73,210
+16,178
| +28% | +$2.15M |
|
442
Boeing
BA
$174B
| $9.56M | 0.05% |
45,630
-169,539
| -79% | -$35.5M |
|
443
McGrath RentCorp
MGRC
$3.09B
| $9.47M | 0.05% |
+81,675
| New | +$9.47M |
|
444
Inhibrx
INBX
$408M
| $9.46M | 0.05% |
662,868
+304,432
| +85% | +$4.34M |
|
445
International Paper
IP
$25.7B
| $9.29M | 0.05% |
+198,291
| New | +$9.29M |
|
|
RDUS
446
DELISTED
Radius Recycling
RDUS
| $9.22M | 0.05% |
+310,500
| New | +$9.22M |
|
447
Apellis Pharmaceuticals
APLS
$3.55B
| $9.19M | 0.05% |
530,923
+312,073
| +143% | +$5.4M |
|
448
Cadence Design Systems
CDNS
$95.6B
| $9.1M | 0.05% |
29,535
-83,184
| -74% | -$25.6M |
|
449
ImmunityBio
IBRX
$2.27B
| $9.1M | 0.05% |
3,445,871
+774
| +0% | +$2.04K |
|
450
Stryker
SYK
$150B
| $8.87M | 0.05% |
22,415
+5,976
| +36% | +$2.36M |
|